Center for Excellence for Cancer Treatment and Immunotherapy Research

About Center for Excellence for Cancer Treatment and Immunotherapy Research

The Center of Excellence for Cancer Treatment and Immunotherapy Research (CECATIR) is a new outpatient clinic facility being established within Piyavate Hospital in Bangkok, Thailand. Piyavate is a private full service hospital serving both Thai and foreign patients. CECATIR provides outpatient oncology/hematology treatment and clinical translational medicine research. CECATIR has a state-of-the-art newly renovated facilities including a chemotherapy infusion center, immunology research laboratory, cryoablation center and fully staffed clinical research center. CECATIR conducts Phase I-III immunotherapy clinical trials in cancer, infectious disease and select autoimmune diseases. CECATIR is supported by Immunovative Therapies, Ltd. in Jerusalem that provides access to advanced immunotherapy drug candidates produced in compliance with GMP, immunomonitoring, central radiology and pathology support, protocol writing and regulatory affairs. Immunovative has developed a novel immunotherapy drug family which are designed to elicit the same mechanism of action as allogeneic stem cell transplant that debulks chemotherapy-resistant solid and hematological tumors, except without GVHD toxicity risk and without requirement for a matched donor or chemotherapy conditioning. Immunovative is currently sponsoring a Phase II/III randomized, controlled trial in third line metastatic colorectal cancer, a Phase II/III non-inferiority trial in locally advanced or recurrent head and neck cancer, a Phase II study in hepatocellular carcinoma and a Phase I study in HIV at the Center. CECATIR is headed by a US-trained and licensed hematology/oncology diplomate and is supported by a team of physicians, nurses and research professionals in cancer and immunotherapy.

This employer is not currently advertising. Why not try our job search?